328 Принципы и практика психофармакотерапии

82. Cassano GB, Castrogiovanni P, Conti I. Drug re­sponses in different anxiety states under benzo-diazepine treatment: some multivariate analyses for evaluation of Rating Scale for Depression sco­res. In: Garratini E, Mussini S, Randall LO, eds. The benzodiazapines. New York: Raven Press, 1973.

83. Klerman GL The use of benzodiazepines in the treatment of depression. Int Drug Ther News 1986; 21: 37-38.

84. Baldessarini RJ. Drugs and the treatment of psy­chiatric disorders. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of ther­apeutics. New York: Macmillan, 1980.

85. Ryan HW, Merrill FB, Scott GE, et al. Increase in suicidal thoughts and tendencies. JAMA 1968; 203:135-137.

86. Weissman MM, Klerman GL The chronic depres­sive in the community: unrecognized and poorly treated. Compr Psychiatry 1977; 18: 523-531.

87. Weissman MM, Myers JK, Thompson WD. Depres­sion and its treatment in a US urban community. Arch Gen Psychiatry 1981; 38:417-421.

88. Fawcett J. Targeting treatment in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990; 51 (Suppl 11): 40-43.

89. Fabre LF, McLendon DM. A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depres­sion. Curr Ther Res 1980; 27:474-482.

90. Feighner JP, Aden GC. Fabre LF, et al. Compari­son of alprazolam, imipramine and placebo in the treatment of depression. JAMA 1983; 249:3057-3064.

91. Ansseau M, Ansoms C, Beckers G, et al. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. J Affec­tive Disord 1984; 7: 287-296.

92. Lenox RH, Shipley JE, Peyser JM, et al. Double-blind comparison of alprazolam versus imipra­mine in the inpatient treatment of major dep­ressive illness. Psychopharmacol Bull 1984; 20: 79-82.

93. Rickels K, Feighner JP, Smith WT. Alprazolam, amitriptyline, doxepin and placebo in the treat­ment of depression. Arch Gen Psychiatry 1985; 42:134-141.

94. Rush AJ, Erman MK, Schlesser MA, et al. Alpra­zolam vs. amitriptyline in depressions with re­duced REM latencies. Arch Gen Psychiatry 1985; 42:1154-1159.

95. Imlah NW. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression. Br J Psychiatry 1985; 146: 515-519.

96. Remick RA, Fleming JAE, Buchanan RA, et al. A comparison of the safety and efficacy of alpra­zolam and desipramine in moderately severe de­pression. Can J Psychiatry 1985; 30: 597-601.

97. Weissman MM, Prusoff BA, Kleber HD, et al. Al­prazolam (Xanax) in the treatment of major de­pression. In: Burrows GD, ed. Clinical and phar­macological studies in psychiatric disorders. London: John Libbey, 1985.

98. Goldberg SC, Ettigi P, Schuiz PM, et al. Alpra­zolam versus imipramine in depressed out-pa­tients with neurovegetative signs. J Affective Dis­ord 1986; 11: 139-145.

99. Rickels K, Chung HR, Csanalosi IB, et al. Alpra­zolam, diazepam, imipramine, and placebo in out­patients with major depression. Arch Gen Psy­chiatry 1987; 44: 862-866.

100. Fawcett J, Edwards JH, Kravitz HM, Jeffries H. Alprazolam: an antidepressant? Alprazolam, de­sipramine, and an alprazolam-desipramine com­bination in the treatment of adult depressed outpatients. J Clin Psychopharmacol 1987; 7: 295-310.

101. Overall JE, Biggs J, Jacobs M, Holden K. Com­parison of alprazolam and imipramine for treat­ment of outpatient depression. J Clin Psychia­try 1987; 48:15-19.

102. Eriksson B, Nagy A, Starmark JE, Thelander U. Alprazolam compared to amitriptyline in the treatment of major depression. Acta Psychiatr Scand 1987; 75:656-663.

103. Borison RL, Sinha D, Geber S, et al. Double-blind evaluation of alprazolam versus placebo in out­patients with major depression. Biol Psychiatry 1989; 25: 54A.

104. O'Shea B. Alprazolam: just another benzodia-zepine? Ir J Psychol Med 1989; 6:89-94.

105. Potter WZ, Rudorfer MV, Manji H. The pharma-cologic treatment of depression. N Engl J Med 1991; 325:633-642.

106. Hu H-Y, Davis JM, Heinze WJ, Pandey GN. Ef­fect of chronic treatment with antidepressants on beta-adrenergic receptor binding in guinea pig brain. Biochem Pharmacol 1980; 29: 2895-2896.

107. Feighner JP. A review of controlled studies of adinazolam mesylate in patients with major